Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity

被引:5
作者
Kano, K
Yamada, Y
Shiraiwa, T
Shimizu, A
Nishikura, K
Arisaka, O
Tomita, S
Ueda, Y
机构
[1] Dokkyo Univ, Sch Med, Dept Pediat, Shimotsuga, Tochigi 3210293, Japan
[2] Dokkyo Univ, Sch Med, Dept Surg & Mol Pathol, Shimotsuga, Tochigi 3210293, Japan
[3] Dokkyo Univ, Sch Med, Dept Pathol, Koshigaya Hosp, Shimotsuga, Tochigi 3210293, Japan
关键词
bone fracture; child; cyclosporine; epidural lipomatosis; nephrotic syndrome; prednisolone;
D O I
10.1111/j.1440-1797.2004.00341.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoid treatment for steroid-dependent nephrotic syndrome (NS) is associated with severe adverse effects, such as bone fractures and epidural lipomatosis. Furthermore, a high trough level of cyclosporine (CsA) over an extended period of time is known to induce CsA nephropathy. We present a girl with steroid-dependent NS and steroid-induced vertebral compression fractures and epidural lipomatosis who was treated with a high-dose of prednisolone after experiencing several relapses. A high CsA trough level (between 147 and 225 ng/mL) over a period of only 5 months was effective in improving the vertebral compression fractures, alleviating the epidural lipomatosis by enabling the discontinuation of prednisolone treatment. Thus, high trough levels of CsA over a short period of time may enable prednisolone to be discontinued in cases of steroid-dependent NS without causing any clinical, histological, serum and/or urinary CsA-related adverse effects.
引用
收藏
页码:414 / 417
页数:4
相关论文
共 50 条
  • [1] CYCLOSPORINE THERAPY IN STEROID-DEPENDENT NEPHROTIC SYNDROME
    WEBB, KL
    SARGENT, P
    BURKE, JR
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1993, 29 (03) : 188 - 191
  • [2] Challenges in acute cyclosporine toxicity in a child with steroid-dependent nephrotic syndrome
    Gulmez, Ruveyda
    Saygili, Seha
    Yilmaz, Esra Karabag
    Agbas, Ayse
    Canpolat, Nur
    PEDIATRIC NEPHROLOGY, 2025, 40 (03) : 707 - 709
  • [3] Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome
    Dehoux, Laurene
    Hogan, Julien
    Dossier, Claire
    Fila, Marc
    Niel, Olivier
    Maisin, Anne
    Macher, Marie Alice
    Kwon, Theresa
    Baudouin, Veronique
    Deschenes, Georges
    PEDIATRIC NEPHROLOGY, 2016, 31 (11) : 2095 - 2101
  • [4] Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil
    Banerjee, Sushmita
    Pahari, Amitava
    Sengupta, Jayati
    Patnaik, Saroj K.
    PEDIATRIC NEPHROLOGY, 2013, 28 (01) : 93 - 97
  • [5] Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus
    Sinha, Manish D.
    MacLeod, Rebecca
    Rigby, Emma
    Clark, A. Godfrey B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (07) : 1848 - 1854
  • [6] Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil
    Sushmita Banerjee
    Amitava Pahari
    Jayati Sengupta
    Saroj K. Patnaik
    Pediatric Nephrology, 2013, 28 : 93 - 97
  • [7] Rituximab for steroid-dependent nephrotic syndrome
    Beco, A.
    Castro-Ferreira, I.
    Coentrao, L.
    Neto, R.
    Sampaio, S.
    Pestana, M.
    CLINICAL NEPHROLOGY, 2010, 74 (04) : 308 - 310
  • [8] Rituximab in Steroid-dependent Nephrotic Syndrome
    El Koumi, Mohamed
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (06) : 502 - 506
  • [9] Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome
    El-Husseini, A
    El-Basuony, F
    Mahmoud, I
    Donia, A
    Sheashaa, H
    Sabry, A
    Hassan, N
    Sayed-Ahmad, N
    Sobh, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (01) : 3 - 8
  • [10] Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome
    Amr El-Husseini
    Fathy El-Basuony
    Ihab Mahmoud
    Ahmed Donia
    Hussein Sheashaa
    Alaa Sabry
    Nabil Hassan
    Nagy Sayed-Ahmad
    Mohamed Sobh
    European Journal of Clinical Pharmacology, 2006, 62 : 3 - 8